BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Meleddu R, Deplano S, Maccioni E, Ortuso F, Cottiglia F, Secci D, Onali A, Sanna E, Angeli A, Angius R, Alcaro S, Supuran CT, Distinto S. Selective inhibition of carbonic anhydrase IX and XII by coumarin and psoralen derivatives. J Enzyme Inhib Med Chem 2021;36:685-92. [PMID: 33602041 DOI: 10.1080/14756366.2021.1887171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Arif N, Shafiq Z, Mahmood K, Rafiq M, Naz S, Shahzad SA, Farooq U, Bahkali AH, Elgorban AM, Yaqub M, El-gokha A. Synthesis, Biological Evaluation, and In Silico Studies of Novel Coumarin-Based 4 H ,5 H -pyrano[3,2- c ]chromenes as Potent β-Glucuronidase and Carbonic Anhydrase Inhibitors. ACS Omega. [DOI: 10.1021/acsomega.2c03528] [Reference Citation Analysis]
2 Arrighi G, Puerta A, Petrini A, Hicke FJ, Nocentini A, Fernandes MX, Padrón JM, Supuran CT, Fernández-bolaños JG, López Ó. Squaramide-Tethered Sulfonamides and Coumarins: Synthesis, Inhibition of Tumor-Associated CAs IX and XII and Docking Simulations. IJMS 2022;23:7685. [DOI: 10.3390/ijms23147685] [Reference Citation Analysis]
3 Kciuk M, Gielecińska A, Mujwar S, Mojzych M, Marciniak B, Drozda R, Kontek R. Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies. J Enzyme Inhib Med Chem 2022;37:1278-98. [PMID: 35506234 DOI: 10.1080/14756366.2022.2052868] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
4 Khatua S, Taraphder S. In the footsteps of an inhibitor unbinding from the active site of human carbonic anhydrase II. Journal of Biomolecular Structure and Dynamics. [DOI: 10.1080/07391102.2022.2048075] [Reference Citation Analysis]
5 Giovannuzzi S, De Luca V, Nocentini A, Capasso C, Supuran CT. Coumarins inhibit η-class carbonic anhydrase from Plasmodium falciparum. J Enzyme Inhib Med Chem 2022;37:680-5. [PMID: 35139744 DOI: 10.1080/14756366.2022.2036986] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Pan Y, Liu T, Wang X, Sun J. Research progress of coumarins and their derivatives in the treatment of diabetes. Journal of Enzyme Inhibition and Medicinal Chemistry 2022;37:616-28. [DOI: 10.1080/14756366.2021.2024526] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Fuentes-Aguilar A, Merino-Montiel P, Montiel-Smith S, Meza-Reyes S, Vega-Báez JL, Puerta A, Fernandes MX, Padrón JM, Petreni A, Nocentini A, Supuran CT, López Ó, Fernández-Bolaños JG. 2-Aminobenzoxazole-appended coumarins as potent and selective inhibitors of tumour-associated carbonic anhydrases. J Enzyme Inhib Med Chem 2022;37:168-77. [PMID: 34894971 DOI: 10.1080/14756366.2021.1998026] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
8 Becerra D, Portilla J, Castillo J. 2-Oxo-2H-chromen-7-yl 4-chlorobenzoate. Molbank 2021;2021:M1279. [DOI: 10.3390/m1279] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Dar'in D, Kantin G, Kalinin S, Sharonova T, Bunev A, Ostapenko GI, Nocentini A, Sharoyko V, Supuran CT, Krasavin M. Investigation of 3-sulfamoyl coumarins against cancer-related IX and XII isoforms of human carbonic anhydrase as well as cancer cells leads to the discovery of 2-oxo-2H-benzo[h]chromene-3-sulfonamide - A new caspase-activating proapoptotic agent. Eur J Med Chem 2021;222:113589. [PMID: 34147910 DOI: 10.1016/j.ejmech.2021.113589] [Cited by in F6Publishing: 7] [Reference Citation Analysis]